So-Young International (NASDAQ:SY – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Citigroup in a report released on Monday, MarketBeat reports. They currently have a $0.80 price target on the stock, down from their prior price target of $1.50. Citigroup’s target price points to a potential upside of 6.13% from the stock’s previous close.
So-Young International Stock Up 2.1 %
SY stock opened at $0.75 on Monday. The stock has a market capitalization of $78.04 million, a price-to-earnings ratio of 37.69 and a beta of 0.90. So-Young International has a 52-week low of $0.69 and a 52-week high of $1.52. The stock’s fifty day simple moving average is $0.87 and its 200-day simple moving average is $1.04.
So-Young International (NASDAQ:SY – Get Free Report) last released its earnings results on Friday, August 23rd. The company reported $0.02 EPS for the quarter. The firm had revenue of $56.06 million during the quarter. So-Young International had a return on equity of 1.32% and a net margin of 2.23%.
Hedge Funds Weigh In On So-Young International
So-Young International Company Profile
So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.
Read More
- Five stocks we like better than So-Young International
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Most Effectively Use the MarketBeat Earnings Screener
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.